Zaldua, J., Butcher, L., Carnicero, J. A., Hawkins, K., Whitley, J., Mothukuri, R., . . . Erusalimsky, J. D. (2022). High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasone. Respiratory Research, 23(1), . doi:10.1186/s12931-022-02220-5

Zaldua, Jun-Cezar, et al. "High Levels of Soluble RAGE Are Associated With a Greater Risk of Mortality in COVID-19 Patients Treated With Dexamethasone." Respiratory Research 23, no. 1 (2022).

Zaldua, Jun-Cezar, et al. "High Levels of Soluble RAGE Are Associated With a Greater Risk of Mortality in COVID-19 Patients Treated With Dexamethasone." Respiratory Research 23.1 (2022).